Deacetylase inhibitors and uses thereof

Details for Australian Patent Application No. 2009274549 (hide)

Owner Dana-Farber Cancer Institute, Inc. President and Fellows of Harvard College

Inventors Tang, Weiping; Bradner, James Elliot; Schreiber, Stuart L.

Agent Davies Collison Cave

Pub. Number AU-A-2009274549

PCT Pub. Number WO2010/011296

Priority 61/082,899 23.07.08 US

Filing date 22 July 2009

Wipo publication date 28 January 2010

International Classifications

C07C 251/86 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

A61K 31/15 (2006.01) - Oximes (CNO)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/011296 Priority application(s): WO2010/011296

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274563-Methods for diagnosis and prognosis of skin cancer

2009274543-Removable attachment for footwear